# PluroGen Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/plurogen-therapeutics

- Industry: Healthcare
- Headquarters: Norristown, US
- Website: www.plurogen.com
- Total disclosed funding: $1.7M
- Latest round: Seed (Apr 13, 2007)
- Investors on record: 3

## About

PluroGen Therapeutics, Inc. is a biotechnology company focused on developing innovative therapeutic solutions aimed at treating severe medical conditions by leveraging advanced drug delivery systems.PluroGen Therapeutics, Inc. was founded in 2003 and is headquartered in Norristown, Pennsylvania, US. The company specializes in therapeutic innovations and has completed 4 deals, with its most recent funding occurring on April 4, 2014. PluroGen raised USD 0.15 million in venture funding at that time, contributing to its total amount raised of USD 0.15 million.PluroGen Therapeutics, Inc. specializes in developing biopharmaceutical products aimed at treating serious medical conditions. Their offerings include advanced drug formulations and delivery systems designed to enhance therapeutic efficacy and patient outcomes. The company’s target market spans healthcare providers and patients requiring novel treatments for challenging medical issues.PluroGen Therapeutics, Inc. operates on a revenue model based on partnerships and licensing agreements, focusing on the development of innovative biopharmaceuticals. The financial structure typically involves client engagements where payment is made for the rights to use their therapeutic solutions, with pricing dependent on the specific agreements established with partners and clients.PluroGen Therapeutics, Inc. is committed to expanding its product line with new therapeutic solutions currently in the design phase, with anticipated launches aimed for late 2025. The company is also planning to enter new geographic markets, specifically targeting Europe and Asia by 2026. The recent funding round completed in April 2014, amounting to USD 0.15 million, will be utilized to support these initiatives, facilitating further research and development efforts.

## Funding rounds

- Seed, Apr 13, 2007, $1.7M — Cato BioVentures, Virginia Active Angel Network, Jefferson Corner Group

## Investors

- Cato BioVentures (https://capitalatlas.ai/funds/cato-bioventures) — Seed
- Virginia Active Angel Network — Seed
- Jefferson Corner Group — Seed